A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2019
Price : $35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PRONTO-Peds
- Sponsors Eli Lilly and Company
- 24 Apr 2019 Status changed from not yet recruiting to recruiting.
- 02 Apr 2019 Planned initiation date changed from 22 Mar 2019 to 22 Apr 2019.
- 18 Mar 2019 Planned initiation date changed from 8 Mar 2019 to 22 Mar 2019.